COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19
Abstract
:1. Main Text
2. Gastrointestinal Manifestations of COVID-19
3. Materials and Methods
4. Results
4.1. Intestinal Perforation
4.2. A Hypothesis on the Role of Thrombosis
Author Contributions
Funding
Conflicts of Interest
Ethics Approval
References
- Menter, T.; Haslbauer, J.; Nienhold, R.; Savic, S.; Hopfer, H.; Deigendesch, N.; Frank, S.; Turek, D.; Willi, N.; Pargger, H.; et al. Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology 2020. [Google Scholar] [CrossRef] [PubMed]
- Sambataro, G.; Giuffrè, M.; Sambataro, D.; Palermo, A.; Vignigni, G.; Cesareo, R.; Crimi, N.; Torrisi, S.; Vancheri, C.; Malatino, L.; et al. The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak. Diagnostics 2020, 10, 619. [Google Scholar] [CrossRef] [PubMed]
- Cabas, P.; Di Bella, S.; Giuffrè, M.; Rizzo, M.; Trombetta, C.; Luzzati, R.; Antonello, R.M.; Parenzan, K.; Liguori, G. Community pharmacists’ exposure to COVID-19. Res. Soc. Adm. Pharm. 2020. [Google Scholar] [CrossRef] [PubMed]
- Hoffmann, M.; Kleine-Weber, H.; Schroeder, S.; Krüger, N.; Herrler, T.; Erichsen, S.; Schiergens, T.S.; Herrler, G.; Wu, N.-H.; Nitsche, A.; et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020, 181, 271–280. [Google Scholar] [CrossRef] [PubMed]
- Effenberger, M.; Grabherr, F.; Mayr, L.; Schwaerzler, J.; Nairz, M.; Seifert, M.; Hilbe, R.; Seiwald, S.; Scholl-Buergi, S.; Fritsche, G.; et al. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut 2020, 69. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Varga, Z.; Flammer, A.J.; Steiger, P.; Haberecker, M.; Andermatt, R.; Zinkernagel, A.S.; Mehra, M.R.; Schuepbach, R.A.; Ruschitzka, F.; Moch, H. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020, 395, 1417–1418. [Google Scholar] [CrossRef]
- Liang, W.; Feng, Z.; Rao, S.; Xiao, C.; Xue, X.; Lin, Z.; Zhang, Q.; Qi, W. Diarrhoea may be underestimated: A missing link in 2019 novel coronavirus. Gut 2020, 69, 1141–1143. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xiao, F.; Tang, M.; Zheng, X.; Liu, Y.; Li, X.; Shan, H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology 2020, 158, 1831–1833. [Google Scholar] [CrossRef] [PubMed]
- Lin, L.; Jiang, X.; Zhang, Z.; Huang, S.; Zhang, Z.; Fang, Z.; Gu, Z.; Gao, L.; Shi, H.; Mai, L.; et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 2020, 69, 997–1001. [Google Scholar] [CrossRef] [PubMed]
- Pan, Y.; Zhang, D.; Yang, P.; Poon, L.L.M.; Wang, Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect. Dis. 2020, 20, 411–412. [Google Scholar] [CrossRef]
- Magro, F.; Lopes, J.; Borralho, P.; Lopes, S.; Coelho, R.; Cotter, J.; De Castro, F.D.; De Sousa, H.T.; Salgado, M.; Andrade, P.; et al. Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels. Gut 2018, 68, 594–603. [Google Scholar] [CrossRef] [PubMed]
- Tahir, M.; Arshid, S.; Fontes, B.; Castro, M.S.; Luz, I.S.; Botelho, K.L.R.; Sidoli, S.; Schwämmle, V.; Roepstorff, P.; Fontes, W. Analysis of the Effect of Intestinal Ischemia and Reperfusion on the Rat Neutrophils Proteome. Front. Mol. Biosci. 2018, 5, 89. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bhayana, R.; Som, A.; Li, M.; Carey, D.; Anderson, M.A.; Blake, M.A.; Catalano, O.A.; Gee, M.S.; Hahn, P.F.; Harisinghani, M.; et al. Abdominal Imaging Findings in COVID-19: Preliminary Observations. Radiology 2020, 201908. [Google Scholar] [CrossRef] [PubMed]
- Zhang, L.; Yan, X.; Fan, Q.; Liu, H.; Liu, X.; Liu, Z.; Zhang, Z. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J. Thromb. Haemost. 2020, 18, 1324–1329. [Google Scholar] [CrossRef] [PubMed]
Characteristics | Patients with Abnormal Fecal Calprotectin N = 21 | Patients without Abnormal Calprotectin N = 4 |
---|---|---|
Age, years | 78.3 (69; 81.5) | 76 (70; 84) |
Gender, Male | 15 (71.4%) | 3 (75%) |
BMI (kg/m2) | 24 (21; 27) | 25 (20; 26) |
Hearth Diseases | 10 (47.6%) | 2 (50%) |
Hypertension | 7 (33.3%) | 2 (50%) |
Previous ACE-Inhibitors | 5 (23.8%) | 2 (50%) |
Active Smokers | 7 (33.3%) | 1 (25%) |
Antibiotic Therapy | 5 (23.8%) | 1 (25%) |
Heparin Therapy | 13 (61.9%) | 2 (50%) |
White Blood Cell Count | 6530 (4050; 7350) | 6110 (4350; 8365) |
Platelets (109/L) | 205 (141;357) | 189 (153; 265) |
PCR (mg/dL) | 31 (24; 91) | 40 (8; 115) |
LDH (U/L) | 290 (195; 381) | 250 (190; 300) |
Ferritin (µg/L) | 645 (520; 1210) | 550 (420; 610) |
Fecal Calprotectin (mg/kg) | 116 (87.5; 243.5) | |
D-Dimer (mg/LFEU) | 1.32 (0.82; 2) | 0.87 (0.5; 1.23) |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Giuffrè, M.; Di Bella, S.; Sambataro, G.; Zerbato, V.; Cavallaro, M.; Occhipinti, A.A.; Palermo, A.; Crescenzi, A.; Monica, F.; Luzzati, R.; et al. COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19. Trop. Med. Infect. Dis. 2020, 5, 147. https://doi.org/10.3390/tropicalmed5030147
Giuffrè M, Di Bella S, Sambataro G, Zerbato V, Cavallaro M, Occhipinti AA, Palermo A, Crescenzi A, Monica F, Luzzati R, et al. COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19. Tropical Medicine and Infectious Disease. 2020; 5(3):147. https://doi.org/10.3390/tropicalmed5030147
Chicago/Turabian StyleGiuffrè, Mauro, Stefano Di Bella, Gianluca Sambataro, Verena Zerbato, Marco Cavallaro, Alessandro Agostino Occhipinti, Andrea Palermo, Anna Crescenzi, Fabio Monica, Roberto Luzzati, and et al. 2020. "COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19" Tropical Medicine and Infectious Disease 5, no. 3: 147. https://doi.org/10.3390/tropicalmed5030147
APA StyleGiuffrè, M., Di Bella, S., Sambataro, G., Zerbato, V., Cavallaro, M., Occhipinti, A. A., Palermo, A., Crescenzi, A., Monica, F., Luzzati, R., & Crocè, L. S. (2020). COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19. Tropical Medicine and Infectious Disease, 5(3), 147. https://doi.org/10.3390/tropicalmed5030147